TY  - JOUR

T1  - Canakinumab for Atherosclerotic Disease

JO  - The New England journal of medicine

UR  - http://eprints.whiterose.ac.uk/126384/

PY  - 2018/01/11

AU  - Rothman AMK

AU  - Morton AC

AU  - Crossman DC

AU  - Investigators MRC-ILAH

ED  - 

DO  - DOI: 10.1056/NEJMc1714635

PB  - Massachusetts Medical Society

VL  - 378

IS  - 2

SP  - 196

EP  - 200

Y2  - 2024/12/22

ER  -